Ophthalmic Imaging in HCHWA-D

Ophthalmic Imaging in HCHWA-D - Ophthalmic Imaging in HCHWA-D

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40430

Enrollment

Registered

2014-10-22

Start date

2014-10-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Cerebral Hemorrhage With Amyloidosis-Dutchtype

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: DNA-proven patients with HCHWA-D or patients with a strong clinical suspicion for HCHWA-D in combination with MRI-scan abnormalities highly suggesting HCHWA-D. Patients must be willing to be informed about their test results and (clinical) diagnosis.

Exclusion criteria

Exclusion criteria: Direct family members of the patients whom genetic testing is not performed and/or are nog willing to be informed about their test results and (clinical) diagnosis; Age-related Macular Dystrophy (AMD); Diabetic Mellitus; Macular dystrophies; Eye traumas; Glaucoma

Design outcomes

Primary

Measure	Time frame
Differences between the opthalmic findings in HCHWA-D patients and controls.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results